IRCT20230222057495N1尚未招募未知
In vivo study of famotidine tablet 40 mg, iranian product compare to the brand one on healthy volunteers
Aria Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Age between 18 to 50 years
- •Non smoking
- •BMI below 30 kg/m2
排除标准
- •Blood pressure below 90/60 or more than 140/90 mmHg
- •Smoking person (more than 10 /day)
- •Using any kinds of medicine, alcohol or opioids during 2 weeks before starting the study
研究者
相似试验
招募中
Unknown
Bioequivalence study of famotidine 40 mg tablets produced by Actoverco pharmaceutical companyThis study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20240804062647N1?Actoverco Pharmaceutical Company24
招募中
Unknown
Bioequivalence study of famotidine 40 mg tabletIRCT20230222057495N12Ramopharmin Pharmaceutical Company24
已完成
不适用
Bioequivalance study of Famotidine 40 mgIRCT20200513047423N5Fatak chemie pars Pharmacy24
尚未招募
不适用
Bioequivalance study of Famotidine 40 mgSubject: Bioequivalence of Famotidine 40 mg Tablet and Comparison of Pharmacokinetic Parameters with Ratiopham Reference Tablet.IRCT20200513047423N9Iran Daru Pharmaceutical Company24
招募中
Unknown
Bioequivalence study of Famotidine 40 mg tabletIRCT20210519051345N32Tabriz University of Medical Sciences24